1 / 1

Survival and Treatment Failure Analysis in Bile Duct and Gallbladder Carcinoma Patients

This study presents the overall survival and treatment failure curves for patients diagnosed with Bile Duct Carcinoma (BDca) and Gallbladder Carcinoma (GBca). Our analysis spans 225 days for overall TTF (Time to Treatment Failure) and 107 days specifically for BDca, with results demonstrating survival rates and failure probabilities (p = 0.4763 for BDca and p = 0.3014 for GBca). The findings highlight critical insights into treatment efficacy and patient prognosis, contributing to a deeper understanding of these malignant conditions.

tallys
Télécharger la présentation

Survival and Treatment Failure Analysis in Bile Duct and Gallbladder Carcinoma Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. mTTF MST Χ Over all225 days Over all107 days ○ BDca234 days BDca117 days p=0.4763 p=0.3014 □ GBca150 days GBca85 days Χ ○ □ Figure 2. Survival and Treatment failure Overall Survival Curve TTF curve (BDca: Bile duct carcinoma GBca: Gallbladder carcinoma)

More Related